# Open WebUI vs Unlearn.AI

Open WebUI records 804,534 monthly visits with -2.8% month-over-month growth and Freemium pricing. Unlearn.AI records 17,107 monthly visits with -32.5% growth and Contact for Pricing pricing.

| Metric | [Open WebUI](https://openaitools.app/tool/open-webui) | [Unlearn.AI](https://openaitools.app/tool/unlearn-ai) |
| :--- | :--- | :--- |
| Website URL | https://openwebui.com | https://unlearn.ai |
| Categories | Large Language Models (LLMs), AI Chatbot, Open Source AI Models, AI Developer Tools | AI Healthcare, AI Research Tool, AI Predictions, AI Models |
| Pricing Model | Freemium | Contact for Pricing |
| Monthly Visits | 804,534 | 17,107 |
| MoM Growth Rate | -2.8% | -32.5% |
| Primary Market | United States | United States |
| Direct Visits | 299,835 | 7,493 |
| Review Score | 4.4 | 4.4 |
| Saved Count | 0 | 1 |
| Supported Platforms | Website | Website |

## Open WebUI

Open WebUI is an open-source, self-hosted interface for working with AI models. Instead of renting access to a single vendor's chatbot, you run the interface on your own hardware or cloud tenancy, then connect whatever models you want: local runtimes such as Ollama, OpenAI-compatible endpoints, Anthropic, or a mix of local and remote. Everything a team produces — conversations, prompts, models, skills and tools — stays in an environment you administer.

The platform has grown well beyond a chat window. Retrieval-augmented generation, web search, document understanding, voice input and output, and vision are built in, and Python tools, functions and pipelines let developers script custom behaviour and share it. On the operations side it offers enterprise features such as SSO, role-based access control, audit logs, data residency options, and on-premises, hybrid or fully air-gapped deployment for regulated environments. White-labeling and custom branding are also available for organizations that want their own look.

Open WebUI is distributed free of charge under an open-source license and can be installed with a single pip or Docker command, with no account required to get running. A separate enterprise offering is available for organizations that want commercial support, compliance guarantees and managed rollout help, which is quoted on contact. A large community maintains a public hub of prompts, models, tools and functions, so much of what teams need is already shared and ready to install.

**Pricing & Plans:** The core platform is free and open source, installable via pip or Docker with no account required. An enterprise tier with support, compliance and deployment assistance is quoted on contact.

- **Any Model, Any Endpoint:** Connect local runtimes like Ollama alongside OpenAI-compatible and Anthropic APIs, and switch between them inside one interface.
- **Retrieval and Search Built In:** RAG over your own documents, web search and citation-aware answers come standard, so responses are grounded in real sources.
- **Python Tools, Functions and Pipelines:** Extend the platform with Python code to add custom tooling, preprocessing, and multi-step pipelines, then share them with others.
- **Enterprise Controls:** SSO, RBAC, audit logs, data residency, and on-premises, hybrid or air-gapped deployment for organisations with strict requirements.
- **Community Hub:** Browse and install prompts, models, skills and tools contributed by hundreds of thousands of community members.

**Strengths:** Free and open source with no account needed to install; Works with local and cloud models through a single interface; Strong privacy posture: your data and models stay on your infrastructure; Extensive enterprise features including SSO, RBAC and audit logs

**Limitations:** Self-hosting requires you to handle servers, updates and backups; Some enterprise capabilities and support sit behind a paid, quote-based tier; Feature depth means a learning curve for non-technical administrators; Local model performance depends heavily on your own hardware

[Profile (Markdown)](https://openaitools.app/tool/open-webui.md)

## Unlearn.AI

Unlearn.AI works with biopharma sponsors and clinical research teams at three points in a trial's lifecycle: before the protocol is finalized, while the study is running, and after readout. In design, teams model the patients they expect to enroll and pressure-test sample size, eligibility criteria, endpoints, and comparators before locking the protocol. The company's PROCOVA method — described as EMA-qualified and FDA-supported — applies twin-based covariate adjustment to reduce sample size in randomized controlled trials while holding statistical power, or to increase power without adding patients.

Mid-study, Unlearn supports pre-specified twin-based analyses that tighten interim estimates without enrolling anyone new, and lets teams re-run design scenarios when new evidence — a competitor readout, a fresh publication, or blinded data drifting from assumptions — changes the picture. After a study reads out, digital twins are used to contextualize population, endpoints, and variability, improving sensitivity across endpoints and helping teams re-evaluate historical trial data with regulatory-aligned methods.

Unlearn publishes concrete case outcomes: a 20% sample-size reduction built into a Phase 1/2 design with roughly $2M in savings, a 33% smaller control arm and four-plus months of enrollment time saved in a re-analysis of completed Phase 3 trials from a top-5 global sponsor, and a completed Phase 3 ALS trial re-analyzed to keep full power with 92 fewer participants. The company partners with sponsors including Trace Neuroscience, QurAlis, Acumen Pharmaceuticals, SOLA Biosciences, VectorY Therapeutics, and CHDI Foundation, and states it works with top global pharma companies. Unlearn does not publish list pricing; engagements are scoped through direct contact.

**Pricing & Plans:** Enterprise, contact-for-pricing model. Unlearn does not publish standard subscription tiers; engagements are scoped per study or program after a conversation with the team.

- **AI-generated patient digital twins:** Model-based forecasts of each participant's clinical outcomes, generated from baseline data already collected, that act as a virtual comparator or as additional information per enrolled patient.
- **PROCOVA design and analysis method:** A twin-based covariate adjustment approach that Unlearn describes as EMA-qualified and FDA-supported, used to reduce sample size in randomized controlled trials while maintaining power.
- **Trial design scenario modeling:** Build and compare design scenarios — endpoints, eligibility criteria, sample size, assumptions — so governance decisions are made with quantified tradeoffs instead of positions.
- **Interim and readout analysis support:** Pre-specified twin-based analyses added to the statistical analysis plan before unblinding, plus twin-adjusted analysis delivered at interim and at readout.
- **Externally controlled study design:** Design single-arm and externally controlled studies where randomization is not an option, selecting eligibility criteria that give open-label studies the best chance of a clear readout.

**Strengths:** Digital twins are generated from data already collected, so no extra patients are required to gain information; Publicly reported, quantified outcomes — sample-size reductions, cost savings, and enrollment time saved — rather than only qualitative claims; Covers the whole trial lifecycle: design, interim, and readout, not just one decision point; Named collaborations with biotech and pharma sponsors, plus regulatory-aligned methodology

**Limitations:** Pricing is not published, so budgeting requires a direct sales conversation; The value proposition depends on regulatory acceptance of twin-based methods, which varies by agency and indication; Best suited to sponsors with existing clinical data and statistical teams; not a self-serve tool; Public metrics come from specific studies and may not transfer directly to other indications

[Profile (Markdown)](https://openaitools.app/tool/unlearn-ai.md)

## Frequently Asked Questions

### How do Open WebUI and Unlearn.AI compare in monthly traffic?

Open WebUI has 804,534 monthly visits, while Unlearn.AI has 17,107. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

Open WebUI has a month-over-month growth rate of -2.8%; Unlearn.AI has -32.5%.

### How does pricing compare?

Open WebUI: Freemium. The core platform is free and open source, installable via pip or Docker with no account required. An enterprise tier with support, compliance and deployment assistance is quoted on contact. Unlearn.AI: Contact for Pricing. Enterprise, contact-for-pricing model. Unlearn does not publish standard subscription tiers; engagements are scoped per study or program after a conversation with the team.

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [Ollama](https://openaitools.app/tool/ollama) | 9,421,973 | +4.3% | Free, Freemium, Paid | Functions primarily as a lightweight CLI runtime for local models rather than a full-featured chat interface. | [.md](https://openaitools.app/tool/ollama.md) |
| 2 | [n8n](https://openaitools.app/tool/n8n) | 4,522,449 | -7.4% | Freemium | Open-source workflow automation built for AI agents and technical teams | [.md](https://openaitools.app/tool/n8n.md) |
| 3 | [Hermes-Agent](https://openaitools.app/tool/hermes-agent-1) | 3,638,741 | -5.4% | Freemium | A free, open-source personal AI agent that learns your projects and works across every messaging app. | [.md](https://openaitools.app/tool/hermes-agent-1.md) |
| 4 | [Clawdbot (OpenClaw)](https://openaitools.app/tool/clawdbot) | 1,903,068 | -25.4% | Paid, Free | Open-source personal AI assistant that runs on your own machine and works from chat apps | [.md](https://openaitools.app/tool/clawdbot.md) |
| 5 | [Dify](https://openaitools.app/tool/dify-ai) | 819,691 | -15% | Freemium | Specializes in visual workflow building and RAG pipelines rather than serving purely as a chat interface. | [.md](https://openaitools.app/tool/dify-ai.md) |
| 6 | [Dr.Oracle](https://openaitools.app/tool/dr-oracle) | 723,847 | -1.2% | Free Trial | Guideline-directed medical answers with citations, built for clinicians | [.md](https://openaitools.app/tool/dr-oracle.md) |
| 7 | [LobeHub](https://openaitools.app/tool/lobehub) | 654,548 | -25% | Freemium | Focuses on collaborative team AI workspaces and plugins, but shares similar open-source architectural goals. | [.md](https://openaitools.app/tool/lobehub.md) |
| 8 | [AnythingLLM](https://openaitools.app/tool/anythingllm) | 512,269 | +12.9% | Freemium | Focuses heavily on privacy-first document chat and local RAG pipelines, but offers fewer general-purpose chat UI features. | [.md](https://openaitools.app/tool/anythingllm.md) |
| 9 | [Upheal](https://openaitools.app/tool/upheal-io) | 347,782 | -2.1% | Freemium, Free Trial, Contact for Pricing | AI therapy notes and an AI-native EHR built for mental health professionals. | [.md](https://openaitools.app/tool/upheal-io.md) |
| 10 | [LibreChat](https://openaitools.app/tool/librechat) | 346,879 | -3.5% | Free | Offers robust multi-provider support and advanced user permission management, but has a slightly different configuration setup. | [.md](https://openaitools.app/tool/librechat.md) |

---
Source: https://openaitools.app/compare/open-webui-vs-unlearn-ai

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)
